重复低强度红光照射辅助治疗儿童青少年近视专家共识(2022)

Expert workgroup of expert consensus on repeated low-level red-light as an alternative treatment for childhood myopia(2022)

重复低强度红光(RLRL)照射辅助儿童青少年近视治疗的研究应用已在国内多地开展,初步临床研究结果显示,RLRL眼部照射能够抑制儿童青少年近视的快速增长,但由于目前尚无相关的统一标准,导致不规范应用的现象时有发生,也增加了不良反应的潜在风险。因此有关专家基于当前的循证证据及结合实践经验,并广泛征求意见,从RLRL照射防控近视基本原理、适用对象、方法及剂量、检查项目及照射频次、设备选择及使用功率、不良反应、终止治疗、与其他方法联合应用问题的建议等8个方面制定《重复低强度红光照射辅助治疗儿童青少年近视专家共识(2022)》,为规范RLRL照射在儿童青少年近视防控中的应用提供指导意见。

Repeated low-level red-light(RLRL)therapy has been adopted into research and practice on childhood myopia control nationwide.Preliminary clinical evidence showed that RLRL has some effect on slowing myopia progression.However,sub-optimal applications could become a challenge,including increase in risk of potential adverse reactions,due to a lack of consolidated standards.Accordingly,based on current evidence and expert consensus,presented as eight aspects including basic mechanism,eligibility,procedures and dosage,clinical examinations,device and power specification,adverse reactions,use termination and combined use with other treatments,this Expert consensus on repeated low-level red-light therapy as an alternative treatment of childhood myopia(2022)was developed,with an aim to standardize this new clinical procedure.